FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$114M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$101M
2
+$15.4M
3
+$15M
4
TARS icon
Tarsus Pharmaceuticals
TARS
+$5.41M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$3.87M

Top Sells

1
+$80.9M
2
+$26.5M
3
+$21.7M
4
PCVX icon
Vaxcyte
PCVX
+$11.4M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$10.2M

Sector Composition

1 Healthcare 98.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$180M 16.96%
8,434,232
2
$101M 9.58%
+9,285,682
3
$71.9M 6.79%
1,095,407
+229,157
4
$69.4M 6.55%
3,566,912
5
$62.9M 5.93%
3,595,026
+882,985
6
$61.5M 5.8%
3,195,403
7
$49.2M 4.64%
5,827,415
8
$47.9M 4.52%
870,636
-1,471,562
9
$39.8M 3.75%
2,971,274
10
$38.9M 3.67%
1,787,405
-522,149
11
$26.4M 2.49%
1,414,823
12
$26.1M 2.46%
1,787,527
+370,370
13
$25.4M 2.4%
2,985,757
-1,200,000
14
$20.2M 1.9%
2,082,093
15
$18.9M 1.78%
2,094,154
-557,600
16
$18.3M 1.72%
899,700
17
$17.1M 1.62%
3,111,551
-334,422
18
$15.5M 1.46%
1,572,192
19
$15.3M 1.44%
673,979
+45,000
20
$14.8M 1.4%
1,501,000
21
$14.1M 1.33%
806,267
+89,505
22
$12.7M 1.2%
5,237,348
23
$12M 1.13%
285,331
+15,000
24
$11.8M 1.12%
250,461
25
$11.3M 1.07%
980,302
-759,228
1
2